Latest filing published 27 Feb 2026 for PFIZER INC, €1.6M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Payal Sahni on record concern Pfizer Inc, in the capacity of chief executive. Over a trading history stretching from 22 February 2021 to 25 February 2026, the count stands at 28 filings.
On the market, this insider has only sold: 1 sale, €68k in total. The rest of the record consists of 19 share grants and 8 option exercises.
The newest entry dates from 27 February 2026: a share grant of €1.2M, in Pfizer Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations